Jeetendra Shantilalji Jain
About Jeetendra Shantilalji Jain
Data last updated:
Jeetendra Shantilalji Jain is a Director at Next Gen Pharma India Private Limited (since 2024), Director at Shri Parshwa Advisors (Opc) Private Limited (since 2022) and Designated Partner at Fintegrity Consulting Llp (since 2023). The companies operate in Pharma and Business Services. The 2 current companies with reported revenue have a combined latest revenue of ₹5.81 Cr; the largest is Next Gen Pharma India Private Limited at ₹5.80 Cr (FY 2023). Earlier, Jeetendra Shantilalji Jain was an Additional Director at Mortechy Finserv Private Limited (from 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Next Gen Pharma India Private Limited U51909DL2004PTC131754 | Director | 23 Jan 2024 | 2004 | ₹5.80 Cr (FY 2023) | Active |
| Shri Parshwa Advisors (Opc) Private Limited U74999MH2022OPC377772 | Director | 02 Mar 2022 | 2022 | ₹44,826 (FY 2025) | Active |
| Fintegrity Consulting Llp AAC-4515 | Designated Partner | 12 May 2023 | 2014 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Mortechy Finserv Private Limited U74999MH2022PTC390777 | Additional Director | 10 Mar 2023 | 2022 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Jeetendra Shantilalji Jain
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anuja Chadha | 08765285 | Next Gen Pharma India Private Limited | Director |
| Kanwaldeep Singh Chadha | 00030566 | Next Gen Pharma India Private Limited | Director |
| Jayesh Singh | 07350035 | Fintegrity Consulting Llp | Designated Partner |
| Rekha Brijbhuvan Singh | 03271476 | Fintegrity Consulting Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jeetendra Shantilalji Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jeetendra Shantilalji Jain
Jeetendra Shantilalji Jain currently holds 3 directorships: Next Gen Pharma India Private Limited (Director, since 23 Jan 2024, revenue ₹5.80 Cr (FY 2023)); Shri Parshwa Advisors (Opc) Private Limited (Director, since 02 Mar 2022, revenue ₹44,826 (FY 2025)); Fintegrity Consulting Llp (Designated Partner, since 12 May 2023).
Jeetendra Shantilalji Jain was first appointed on 02 Mar 2022 as Director at Shri Parshwa Advisors (Opc) Private Limited. The most recent appointment on record is 23 Jan 2024 at Next Gen Pharma India Private Limited.
The 2 current companies of Jeetendra Shantilalji Jain that report revenue have a combined latest revenue of ₹5.81 Cr: Next Gen Pharma India Private Limited ₹5.80 Cr (FY 2023); Shri Parshwa Advisors (Opc) Private Limited ₹44,826 (FY 2025).
Jeetendra Shantilalji Jain held 1 earlier board appointment: Mortechy Finserv Private Limited (Additional Director, from 10 Mar 2023).
The current boards of Jeetendra Shantilalji Jain's companies include Anuja Chadha (Next Gen Pharma India Private Limited), Kanwaldeep Singh Chadha (Next Gen Pharma India Private Limited), Jayesh Singh (Fintegrity Consulting Llp), Rekha Brijbhuvan Singh (Fintegrity Consulting Llp).